Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Chronic Heart Failure- Market Insight, Epidemiology and Market Forecast -2030
... trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Heart Failure market report provides current treatment practices, emerging drugs, Chronic Heart Failure market share of the individual ... Read More
-
Atrial Fibrillation- Market Insight, Epidemiology and Market Forecast -2030
... United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Atrial Fibrillation market report provides current treatment practices, emerging drugs, Atrial Fibrillation market share of the individual therapies, current and forecasted Atrial ... Read More
-
Myocardial Infarction - Market Insight, Epidemiology and Market Forecast -2030
... the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Myocardial Infarction market report provides current treatment practices, emerging drugs, Myocardial Infarction market share of the individual therapies, current and forecasted ... Read More
-
No Option Refractory Disabling Angina (NORDA) Market Insight, Epidemiology and Market Forecast -2030
... as the No Option Refractory Disabling Angina (NORDA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The No Option Refractory Disabling Angina (NORDA) market report provides current ... Read More
-
Angina - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
... patents (US & EU), historical and forecasted sales till 2023. It further provides the marketed products API manufacturer details for United States, Europe, China, and India. The report also covers the emerging Phase III pipeline ... Read More
-
Ischemic Stroke- Market Insight, Epidemiology and Market Forecast -2030
... United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Ischemic Stroke market report provides current treatment practices, emerging drugs, Ischemic Stroke market share of the individual therapies, current and forecasted Ischemic ... Read More
-
Heart failure (HF) with Reduced Ejection Fraction (HFrEF) Market Insight, Epidemiology and Market Forecast -2030
... forecasted epidemiology as well as the Heart failure (HF) with Reduced Ejection Fraction (HFrEF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Heart failure (HF) with ... Read More
-
Acute ischemic stroke (AIS)- Market Insight, Epidemiology and Market Forecast -2030
... stroke (AIS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acute ischemic stroke (AIS) market report provides current treatment practices, emerging drugs, Acute ischemic stroke (AIS) ... Read More
-
Acute Coronary Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
... covers their product details, patents (US & EU), historical and forecasted sales till 2023. It further provides the marketed products API manufacturer details for United States, Europe, China, and India. The report also covers the ... Read More
-
Ischemic Stroke - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
... product details, patents (US & EU), historical and forecasted sales till 2023. It further provides the marketed products API manufacturer details for United States, Europe, China, and India. The report also covers the emerging Phase ... Read More
-
Heart Failure: Global Drug Forecast and Market Analysis to 2028
... meet the demands of the body with a sufficient blood supply. This can be due to structural or functional cardiac abnormalities which can be caused by unexpected injury such as myocardial infarction, or an underlying ... Read More
-
Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Dise
... Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026 The global gene therapy market was valued at $393.35 million in 2018, and is estimated to reach $6,205.85 million by 2026, registering a ... Read More
-
Cardiovascular Prosthetic Devices - Medical Devices Pipeline Assessment, 2019
... stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides ... Read More
-
Myocardial Ischemia Global Clinical Trials Review, H2, 2019
... line data relating to the clinical trials on Myocardial Ischemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
-
Chronic Stable Angina Global Clinical Trials Review, H2, 2019
... report provides top line data relating to the clinical trials on Chronic Stable Angina. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Acute Heart Failure Global Clinical Trials Review, H2, 2019
... report provides top line data relating to the clinical trials on Acute Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Heart Failure: Epidemiology Forecast to 2028
... the metabolic needs of the body. Heart Failure (HF) commonly occurs in people older than 50 years of age, and severity increases progressively with age. The symptoms can develop quickly, such as in Acute Heart ... Read More
-
Acute Coronary Syndrome Global Clinical Trials Review, H2, 2019
... report provides top line data relating to the clinical trials onAcute Coronary Syndrome . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Dyslipidemia Global Clinical Trials Review, H2, 2019
... to the clinical trials on Dyslipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ... Read More
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User, and Region - Global Forecast to 2024
... is projected to grow at a CAGR of 7.3% during the forecast period.” The global neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR ... Read More
-
The 2021-2026 World Outlook for Cardiovascular Information Systems (CVIS)
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2021-2026 World Outlook for Heart Attack Diagnostics
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2021-2026 World Outlook for Cardiovascular Catheters
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2021-2026 World Outlook for Cardiovascular and Soft Tissue Repair Patches
... are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These ... Read More
-
Global Cardiovascular Therapeutics Market Research Report 2019-2023
... Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main ... Read More
